← Back to Search

AGPM for English Speakers for Acute Lymphoblastic Leukemia

N/A

Recruiting

Led By Andrew A Dwyer, PhD

Research Sponsored by Boston College

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Able to provide opt-in electronic informed consent

Adult (18+ yrs.)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to two weeks

Awards & highlights

Study Summary

"This trial aims to test a questionnaire about attitudes towards genomics and precision medicine in both English and Spanish. The goal is to validate the Spanish version of the questionnaire among Hispanic, Latino/a, or Latin

Who is the study for?

This trial is for individuals identifying as Hispanic, Latino/a, or Latinx who have been diagnosed with Acute Lymphoblastic Leukemia. The study aims to include participants to validate a Spanish version of an attitudes survey on genomics and precision medicine.Check my eligibility

What is being tested?

The trial is testing the reliability of two versions of a survey called 'Attitudes Toward Genomics and Precision Medicine' (AGPM), one in English and another in Spanish, among people from specific ethnic backgrounds.See study design

What are the potential side effects?

Since this trial involves completing surveys rather than medical treatments, there are no direct physical side effects associated with participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can give my consent electronically.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to two weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to two weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to two weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Psychometric properties

Secondary outcome measures

Health literacy/numeracy

Trial Design

2Treatment groups

Experimental Treatment

Group I: AGPM for Spanish SpeakersExperimental Treatment1 Intervention

Participants identifying as Hispanic, Latino/a, or Latinx whose primary language is Spanish

Group II: AGPM for English SpeakersExperimental Treatment1 Intervention

Participants identifying as Hispanic, Latino/a, or Latinx whose primary language is English

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Boston CollegeLead Sponsor

38 Previous Clinical Trials

47,319 Total Patients Enrolled

Andrew A Dwyer, PhDPrincipal InvestigatorBoston College

2 Previous Clinical Trials

1,239 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for patient enrollment in the ongoing recruitment phase of this clinical trial?

"According to the details available on clinicaltrials.gov, this investigation is presently enrolling participants. The trial was originally listed on April 14, 2024 and last revised ten days later on April 24, 2024."

Answered by AI

What is the current number of participants being recruited for this medical study?

"Indeed, information on clinicaltrials.gov indicates that recruitment for this trial is ongoing. The trial was initially posted on April 14, 2024 and the most recent update was made on April 24, 2024. Enrollment of approximately 1000 patients will take place at a single designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM).

2024. "Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM).". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06386861.

All > Paid Studies Boston